Accedi a banche dati online | Convegnodetail
mail
Anteprima di stampa
 
 

Next Generation Kinase Inhibitors Summit

Evvnt Promotion / evvnt
-
29.03.2022 - 31.03.2022  Boston Park Plaza, 50 Park Plaza, 02116 Boston, Massachusetts, USA
Time: 13:00 to 16:45
 
Temi della conferenza
Celebrating 20 years of FDA approval and high efficacy profiles, kinase inhibitors have changed the face of oncology treatment. However, increasing resistance and safety issues limit the success of existing kinase inhibitor classes.
Professional congress organizer (PCO)
Hanson Wade
Annotazioni
Brochure: https://go.evvnt.com/944626-0?pid=4832

Speakers: Leslie Cousens, Senior Director, Search and Evaluation, Respiratory and Immunology, AstraZeneca, Markus Queisser, Scientific Director, GlaxoSmithKline, and more.
 

Informazioni ed Iscrizioni:

https://go.evvnt.com/944626-1?pid=4832
Mr. Hanson Wade
 
Categorie
Medicina General
Lingua
Inglese
Quote del Congresso
USD 2599.00 to USD 4348.00
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."

AGEM - Arbeitsgemeinschaft Ethnologie und MedizinÖsterreichische Akademie der ÄrzteÖsterreichisches Rotes KreuzOÖ Gebietskrankenkasse, Referat für Wissenschaftskooperation newTreeÄrztekammer für WienHilfswerk AustriaAlumni Club Medizinische Universität Wien